Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: a meta-analysis of five randomised controlled trials

Leuk Lymphoma. 2009 Mar;50(3):457-9. doi: 10.1080/10428190802654501.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Odds Ratio
  • Premedication*
  • Randomized Controlled Trials as Topic
  • Remission Induction / methods
  • Sample Size

Substances

  • Granulocyte Colony-Stimulating Factor